Financial Data and Key Metrics Changes - The company reported a quorum with 8,569,618 shares of common stock entitled to vote at the meeting, indicating strong shareholder engagement [5] - The preliminary voting results showed that all proposals, including the election of directors and amendments to the equity incentive plan, were approved, reflecting shareholder support for the company's strategic direction [12] Business Line Data and Key Metrics Changes - The company emphasized its focus on advancing its late-stage pipeline, particularly in multiple myeloma, which is a core area of revenue generation [17] Market Data and Key Metrics Changes - The management acknowledged the competitive nature of the myeloma market and the importance of progressing Phase III trials to create new standards of care and enhance shareholder value [18] Company Strategy and Development Direction - The company is committed to maximizing shareholder value by focusing on its late-stage pipeline and exploring alternatives to extend its cash runway [17][18] - The management is actively working to create long-term shareholder value through the success of its commercial organization and product revenue [18] Management's Comments on Operating Environment and Future Outlook - Management expressed understanding of shareholder frustrations regarding stock performance and reiterated their commitment to advancing clinical trials and generating revenue [18] - The company is focused on addressing high unmet needs in the market, which is critical for both patient outcomes and shareholder value [17] Other Important Information - The meeting was conducted virtually, allowing shareholders to participate and submit questions online, demonstrating the company's commitment to transparency and engagement [3] Q&A Session Summary Question: Why are patients and investors best served by the current path given potential noncompliance with lender requirements? - Management highlighted their focus on maximizing shareholder value and advancing their late-stage pipeline to serve patients better and grow revenues [17] Question: What is the plan to maximize shareholder value given insufficient cash runway? - Management acknowledged shareholder frustrations and emphasized their commitment to building shareholder value through progressing Phase III trials and focusing on product revenue [18] Conclusion - The meeting concluded with no further questions, indicating a clear communication of the company's strategies and future outlook [20]

Abercrombie & Fitch (ANF) Q1 2026 Earnings Call May 28, 2025 08:30 AM ET Company Participants Mohit Gupta - VP - Investor RelationsFran Horowitz - CEO & DirectorRobert Ball - SVP & CFODana Telsey - CEO and Chief Research OfficerCorey Tarlowe - SVP - Equity ResearchScott Lipesky - EVP & COOMarni Shapiro - Managing PartnerAlexandra Straton - Equity Research Managing DirectorMauricio Serna - Executive DirectorRick Patel - Managing DirectorJanet Kloppenburg - President Conference Call Participants Matt Boss - E ...

Financial Data and Key Metrics Changes - Total company revenue for the fourth quarter decreased by 15% year-over-year to $1 billion, slightly better than expectations [29] - The company reported a net loss of $581 million, resulting in a diluted loss per share of $4.9, primarily due to a non-cash tax valuation allowance [29][38] - Gross margin declined to 61%, down 170 basis points from the prior year, primarily due to inventory actions taken during the quarter [33] Business Line Data and Key Metrics Changes - Michael Kors revenue decreased by 16% compared to the prior year, with global retail sales down mid-teens and wholesale sales declining double digits [10][31] - Jimmy Choo revenue decreased by 3%, with global retail sales declining high single digits while wholesale increased high teens [19][32] - Michael Kors gross margin was 58.6%, down from 60.8% last year, while Jimmy Choo's gross margin was 66.2%, down from 70.1% [34] Market Data and Key Metrics Changes - Revenue in the Americas decreased by 13%, EMEA declined by 14%, and Asia saw a decrease of 23% [30][32] - For Jimmy Choo, revenue in the Americas decreased by 7%, while EMEA revenue increased by 9% and Asia revenue declined by 16% [32] Company Strategy and Development Direction - The company announced the pending sale of Versace to focus on growth opportunities within Michael Kors and Jimmy Choo, aiming to reduce debt and reinstate a share repurchase program [5][6] - Strategic initiatives include enhancing brand desirability, improving product offerings, and stabilizing the wholesale business [7][8][19] - The company plans to renovate approximately 50% of the Michael Kors store fleet over the next three years to drive sales recovery [16][48] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future despite a challenging macro environment, citing early signs of improvement in sales momentum and consumer engagement [6][17] - The company anticipates total revenue for fiscal 2026 to be between $3.3 billion and $3.4 billion, with gradual progression expected as strategic initiatives gain traction [45] Other Important Information - The company plans to use proceeds from the sale of Versace to reduce debt, which is expected to significantly lower interest expenses [41] - The company is proactively managing tariff risks and expects to mitigate their impact over time through sourcing optimization and potential price increases [44][70] Q&A Session Summary Question: Can you speak to the comfort in the troughing revenue expectations and margin degradation? - Management highlighted a significant improvement in Michael Kors retail performance, with a near flat comp in the current quarter compared to a 15% decline previously, driven by strong full-price sell-throughs and effective storytelling [58][60] Question: What is the wholesale outlook for Michael Kors this year? - Management indicated that discussions with wholesale partners have been positive, with increased commitments due to the successful new storytelling and product initiatives [74][76] Question: What strategies are in place to drive traffic and conversion? - Management emphasized the importance of marketing initiatives, data analytics, and influencer programs to engage consumers and drive traffic, noting that conversion rates have remained strong [82][84] Question: Can you elaborate on the strategies to improve the sales trajectory of Michael Kors? - Management acknowledged past missteps but emphasized a return to the brand's heritage and pricing strategy that aligns with consumer expectations, aiming for sustainable growth [90][92] Question: What is the timeline for achieving steady state pricing? - Management expects to reach the desired pricing levels by the fall season, having already made significant adjustments to align with historical price points [105]

Photronics (PLAB) Q2 2025 Earnings Call May 28, 2025 08:30 AM ET Company Participants Ted Moreau - VP - Investor RelationsFrank Lee - Chief Executive OfficerGeorge Macricostas - Executive ChairmanEric Rivera - CFOTom Diffely - Director Of Institutional ResearchChristopher Progler - Executive Vice President, Chief Technology Officer, Strategic Planning Conference Call Participants Gowshi Sriharan - Analyst Operator Good day, and thank you for standing by. Welcome to the Photronics Second Quarter Fiscal twent ...

Monro (MNRO) Q4 2025 Earnings Call May 28, 2025 08:30 AM ET Company Participants Felix Veksler - VP - IRPeter Fitzsimmons - President & CEOBrian D'Ambrosia - Executive VP of Finance, CFO & TreasurerDavid Lantz - Equity Research - Hardline RetailBret Jordan - Managing Director Conference Call Participants Thomas Wendler - Analyst Operator Good morning, ladies and gentlemen, and welcome to Monro, Inc. Earnings Conference Call for the Fourth Quarter and Full Year of Fiscal twenty twenty five. At this time, all ...

Phreesia (PHR) Q1 2026 Earnings Call May 28, 2025 08:30 AM ET Company Participants Balaji Gandhi - CFOChaim Indig - Co-Founder, CEO & DirectorAnne Samuel - Executive DirectorJailendra Singh - Managing DirectorRichard Close - Managing DirectorJohn Ransom - Managing Director, Director of Healthcare ResearchWilliam Jellison - Associate VPJeff Garro - Managing DirectorScott Schoenhaus - Managing DirectorJared Haase - Equity Research AssociateAaron Kimson - Vice President Conference Call Participants Jessica Tas ...

Abercrombie & Fitch (ANF) Q1 2026 Earnings Call May 28, 2025 08:30 AM ET Speaker0 Good day, and welcome to the Abercrombie and Finch First Quarter Fiscal Year twenty twenty five Earnings Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Today's conference is being recorded. At this time, I would like to turn the conference over to Mo Gupta. Please go ahead. Speaker1 Thank you. Good morning, and welcome to our first ...

Financial Performance and Key Metrics - Revenue for Q1 2026 was $115.9 million, representing a 15% year-over-year increase [9] - Adjusted EBITDA was $20.8 million, an increase of 16.7% year-over-year, with an adjusted EBITDA margin of 18% [10] - Average healthcare services clients increased to 4,411, up 70 from the prior quarter and 346 from the prior year [9] - Total revenue per average healthcare services client was $26,283, up 6% year-over-year and 4% quarter-over-quarter [9] - Cash and cash equivalents at the end of the quarter were $90.9 million, compared to $84.2 million in the prior quarter [10] - Positive operating cash flow of $14.9 million, up $15.6 million year-over-year, and positive free cash flow of $7.5 million, up $13.7 million year-over-year [11] Business Line Performance - The company is focused on delivering scalable products that drive meaningful outcomes for patients and providers, with AI integration across all aspects of the organization [6] - The company is maintaining its revenue outlook for fiscal year 2026 at a range of $472 million to $482 million, with an updated adjusted EBITDA outlook of $85 million to $90 million [12] Market Data and Key Metrics - The company is reiterating its outlook on average healthcare services clients (AHSCs) to reach approximately 4,500 in fiscal year 2026 [12] Company Strategy and Industry Competition - The company emphasizes product-led growth and aims to allocate capital to drive long-term shareholder value [6] - Management highlighted the importance of delivering products that provide value, which is crucial in a competitive market [23] Management Commentary on Operating Environment and Future Outlook - Management noted that conversations with customers remain strong, and the company has been resilient amid macroeconomic volatility [15] - The company is optimistic about its ability to grow its network and expand offerings, driven by a strong balance sheet and growing free cash flow [6][11] Other Important Information - The company has a share repurchase plan for up to 2.5 million shares, aimed at being opportunistic in response to market conditions [80][82] - The Medifine acquisition is still in its early stages, but it is expected to contribute to revenue growth in the future [94][96] Q&A Session Summary Question: Insights on network solutions growth and customer conversations - Management indicated that strong product development and a capable network solutions team are driving growth, with no significant hesitancy reported from customers [15][18] Question: Provider market conversations and outlook - Management noted that conversations with providers remain focused on delivering value through products, with no significant changes in the competitive landscape [22][23] Question: ROI visibility for network solutions customers - Management explained that campaigns can be adjusted based on client needs, and the company has a strong ROI, which drives continued investment from clients [27][29] Question: Sales and marketing performance - Management highlighted that previous investments in sales and marketing are yielding returns, with expectations for consistent expense trends moving forward [34][35] Question: Capital deployment opportunities - Management stated that while the cash position is improving, the evaluation of inorganic opportunities remains consistent, focusing on the best approach to growth [39][41] Question: Impact of flu season on performance - Management clarified that while there are seasonal factors, the introduction of new products like the patient bill pay product is contributing to volume growth [50][51] Question: Labor strategy and expense trajectory - Management explained that recent headcount changes were due to consolidation rather than new hiring, and the expense trajectory is expected to remain stable [53][54] Question: Proposed legislation on drug advertisements - Management indicated that while legislation is always a topic, the focus remains on the value proposition of their platform, which is differentiated [56][58] Question: Network solutions seasonality - Management noted that fluctuations in revenue are more related to program pacing rather than strict seasonality [60][61] Question: Subscription revenue growth - Management confirmed that the growth in revenue per provider client reflects successful product introductions and expansion within existing clients [65][67] Question: AI's impact on competitive landscape - Management observed that AI is enhancing their product offerings and driving value for clients, with a shift towards being a trusted partner in the market [74][76] Question: Share repurchase plan motivation - Management described the share repurchase plan as a means to be opportunistic in response to market volatility, without indicating a change in capital allocation strategy [80][82] Question: Cash conversion rates and payment processing revenue - Management indicated that cash conversion rates are expected to resemble Q1 performance for the rest of the year, with payment processing revenue following historical trends [86][88] Question: Monetization of Medifine offering - Management stated that Medifine is in the early stages of monetization but is expected to grow as the network expands [94][96]

Financial Data and Key Metrics Changes - Total company revenue for Q4 2025 was $1 billion, a decrease of 15% compared to the prior year, slightly better than expectations [27] - The company reported a net loss of $581 million, resulting in a diluted loss per share of $4.9, primarily due to a non-cash tax valuation allowance [27][35] - Gross margin decreased to 61%, down 170 basis points from the prior year, primarily due to inventory actions taken during the quarter [31][32] Business Line Data and Key Metrics Changes - Michael Kors revenue decreased by 16% compared to the prior year, with global retail sales down mid-teens and wholesale sales declining double digits [29][30] - Jimmy Choo revenue decreased by 3% compared to the prior year, with global retail sales declining high single digits while wholesale increased high teens [30] - Michael Kors gross margin was 58.6%, down from 60.8% last year, while Jimmy Choo's gross margin was 66.2%, down from 70.1% [32] Market Data and Key Metrics Changes - Revenue in The Americas decreased by 13%, EMEA declined by 14%, and Asia saw a decrease of 23% [28][30] - In Jimmy Choo, revenue in The Americas decreased by 7%, while EMEA revenue increased by 9% and Asia revenue declined by 16% [30] Company Strategy and Development Direction - The company plans to focus resources on Michael Kors and Jimmy Choo following the pending sale of Versace, aiming to maximize value and reduce debt levels [4][5] - Strategic initiatives include enhancing brand desirability, improving product offerings, and stabilizing the wholesale business [6][10] - The company aims to grow Michael Kors to $4 billion in revenue and Jimmy Choo to $800 million, while restoring operating margins to the double-digit range [25] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future despite a challenging macro environment, focusing on strategic initiatives to improve sales trends [5][24] - Early signs of improvement in sales momentum and key indicators such as consumer database growth and store traffic were noted [16][17] - Management expects trends to improve throughout fiscal 2026, positioning the company for growth in fiscal 2027 and beyond [24][50] Other Important Information - The company plans to renovate approximately 50% of the Michael Kors store fleet over the next three years, with an estimated cost of $350 million [47] - The anticipated impact of tariffs is expected to increase the cost of goods sold by approximately $60 million in fiscal 2026 [42] - The company will reclassify Versace as a discontinued operation beginning in fiscal 2026, excluding it from future non-GAAP results [3] Q&A Session Summary Question: Discussion on revenue expectations and margin degradation - Management expressed optimism about revenue growth based on early Q1 trends, with significant improvements in Michael Kors retail performance and strong full-price sell-throughs [56][58] - Concerns about margin degradation were attributed to tariff impacts and inventory actions, with plans to mitigate these effects over time [65] Question: Wholesale outlook for Michael Kors - Management indicated that discussions with wholesale partners have been positive, with increased commitments from some partners and successful launches on platforms like Amazon [72][74] Question: Strategies to drive traffic and conversion - Management highlighted the importance of marketing initiatives, storytelling, and data analytics to engage consumers and drive traffic, noting improvements in conversion rates [80][81] Question: Strategies to improve sales trajectory for Michael Kors - Management acknowledged past missteps and emphasized a return to the brand's heritage and pricing strategies that resonate with consumers, aiming for sustainable growth [90][92] Question: Pricing strategy and its implications - Management expects to achieve a steady pricing state by the fall season, with adjustments made to align with historical price points while evaluating potential price increases to mitigate tariff risks [100]

Financial Data and Key Metrics Changes - The company reported a significant revenue increase from virtually zero in 2023 to $5 billion in 2024 for its MI300 product, marking the fastest ramp of any product in its history [13] - The client business revenue grew by 68% year-over-year in the first quarter, with two-thirds of that growth attributed to average selling price (ASP) increases [48] Business Line Data and Key Metrics Changes - The MI300 and MI325 are AMD's first explicit data center accelerator products, with a strong ramp in AI capabilities over the past year [12][13] - The company is focusing on enhancing its Instinct family, particularly in inference workloads, which have shown significant performance advantages over competitors [21][22] Market Data and Key Metrics Changes - There has been a substantial investment in AI capabilities across the industry, leading to a rationalization phase where businesses are now targeting specific areas for productivity improvements [7][8] - The enterprise market is increasingly adopting AI, with a hybrid model emerging where companies utilize both on-premises and cloud solutions for their AI workloads [29][30] Company Strategy and Development Direction - The company is committed to a fast cadence of new product releases, aiming to maintain leadership in both CPU and GPU markets while focusing on total cost of ownership advantages [16] - The strategy includes enhancing networking capabilities and partnerships to broaden the inference workloads and customer engagements [25][26] Management's Comments on Operating Environment and Future Outlook - Management highlighted the importance of AI in driving overall demand for computation and the need for businesses to refresh their IT infrastructure to support both traditional and AI workloads [11][52] - There is confidence in margin strength for the second half of the year, driven by a favorable mix in the client and server segments, despite challenges in the data center GPU franchise [51][56] Other Important Information - The company has transitioned to biweekly software releases for its ROCm stack to improve performance and support for the community [35][36] - The acquisition of ZT Systems has strengthened the company's capabilities in RackScale design, enhancing performance and manufacturability [40][41] Q&A Session Summary Question: What are the key problems that customers are trying to solve today? - The focus is on scaling AI capabilities and driving technology forward, with a significant investment in AI infrastructure over the past 12-18 months [7][8] Question: How is the company positioned in the AI market? - The company has seen a strong ramp in its MI300 product and is committed to a fast cadence of new product releases to maintain leadership in AI [12][16] Question: What is the outlook for the enterprise AI adoption? - Enterprises are increasingly adopting a hybrid model for AI, leveraging both on-premises and cloud solutions, particularly in industries like health sciences [29][30] Question: How does the company plan to address software maturity? - The company has focused on hardening its software stack and is now releasing updates biweekly to improve performance and support for the community [35][36] Question: What is driving confidence in margin strength for the second half of the year? - The company anticipates strong growth in commercial PCs and server segments, with a favorable mix contributing to margin improvements [52][56]